GPX2 and breast cancer: GPx2 knockdown (KD) in murine and human BC cells stimulates ROS/HIF1α/VEGFA signaling, which enhanced malignant progression via vascular modulation, resulting in poor perfusion, hypoxia, and a shift from OXPHOS to aerobic glycolysis (the Warburg effect).